×
About 448 results

ALLMedicine™ Primary Pulmonary Hypertension Center

Research & Reviews  128 results

Endothelial Cell Dysfunction in Pulmonary Hypertension
https://clinicaltrials.gov/ct2/show/NCT00098072

Jun 24th, 2022 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...

Idiopathic Pulmonary Arterial Hypertension
https://emedicine.medscape.com/article/301450-print

May 27th, 2022 - Practice Essentials Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease characterized by elevated pulmonary artery pressure with no apparent cause. IPAH is also termed WHO Group I pulmonary hypertension (PH), precapillary pulmonary...

Idiopathic Pulmonary Arterial Hypertension
https://emedicine.medscape.com/article/301450-overview

May 27th, 2022 - Practice Essentials Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease characterized by elevated pulmonary artery pressure with no apparent cause. IPAH is also termed WHO Group I pulmonary hypertension (PH), precapillary pulmonary...

Idiopathic Pulmonary Arterial Hypertension
http://emedicine.medscape.com/article/301450-overview

May 27th, 2022 - Practice Essentials Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease characterized by elevated pulmonary artery pressure with no apparent cause. IPAH is also termed WHO Group I pulmonary hypertension (PH), precapillary pulmonary...

Aerobic Exercise in Patients With Pulmonary Hypertension
https://clinicaltrials.gov/ct2/show/NCT00678821

May 19th, 2022 - We propose a randomized trial to determine the safety and effectiveness of aerobic exercise for patients who have primary pulmonary hypertension (PH) or PH secondary to interstitial lung disease (ILD). This project will be the first in a series of...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  32 results

Endothelial Cell Dysfunction in Pulmonary Hypertension
https://clinicaltrials.gov/ct2/show/NCT00098072

Jun 24th, 2022 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...

Aerobic Exercise in Patients With Pulmonary Hypertension
https://clinicaltrials.gov/ct2/show/NCT00678821

May 19th, 2022 - We propose a randomized trial to determine the safety and effectiveness of aerobic exercise for patients who have primary pulmonary hypertension (PH) or PH secondary to interstitial lung disease (ILD). This project will be the first in a series of...

Comparison of PD1+T Cell Expression in Peripheral Blood for Cardiac Function Prognosis in Patients With Acute MI
https://clinicaltrials.gov/ct2/show/NCT05251987

Feb 23rd, 2022 - Myocardial infarction is a serious common disease in human beings. Although many patients with acute myocardial infarction survive with the improvement of medical technology in recent years, studies have shown that cardiac remodeling caused by myo...

Pulmonary Hypertension in Haemodialysis Patients :Frequency and Risk Factors
https://clinicaltrials.gov/ct2/show/NCT03310229

Jan 20th, 2021 - Primary whose mechanisms are incompletely known, is another vascular disease entity recently described in chronic kidney disease particularly in patients undergoing haemodialysis. It corresponds to 5th subtype of World Symposium on Pulmonary Hyper...

Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military
https://clinicaltrials.gov/ct2/show/NCT04058132

Aug 19th, 2019 - Background and significance: Currently, more that 5.3 million Americans (or 2% of the population) live with disabilities resulting from TBI. Among OEF/OIF Veterans, TBI incidence estimates as high as 23% have been reported, with mild TBI (mTBI) be...

see more →

News  13 results

Peering into My Own Genome
https://www.medpagetoday.com/genetics/genetictesting/53088

Aug 16th, 2015 - I have looked into my genome and seen ... nothing much to worry about. I carry 15 rare genetic variants that have been associated with some form of disease, but I am heterozygous for all of them -- I have one intact copy of the same gene. So I car...

Avenues for protecting against vasculopathy in systemic sclerosis
https://www.mdedge.com/dermatology/article/82448/lupus-connective-tissue-diseases/avenues-protecting-against-vasculopathy/page/0/1

May 19th, 2014 - Endothelin inhibitors Endothelin inhibitors also may play a role in vascular protection. Endothelin is secreted in scleroderma and is a potent vasoconstrictor.

RVH or Posterior MI? Make the Diagnosis
https://www.medscape.com/viewarticle/762321_2

Apr 20th, 2012 - Answer Right ventricular hypertrophy Discussion In this tracing, QRS axis tends to the right axis deviation (RAD), which should make one think of right ventricular hypertrophy (RVH) first. After the RAD, all other diagnostic features of RVH are fo...

Products Liability
https://www.mdedge.com/familymedicine/article/46858/products-liability
Family Practice News;

Dec 29th, 2011 - Question: A woman developed primary pulmonary hypertension (PPH) 4 years after she had stopped using the prescription weight-loss drug, fenfluramine. The drug is known to cause valvular heart lesions as well as PPH.

MRI Identifies Metabolic Abnormalities in Brain After ECMO
https://www.staging.medscape.com/viewarticle/754137

Nov 28th, 2011 - November 28, 2011 (Chicago, Illinois) — Approximately half of the neonates who receive extracorporeal membrane oxygenation (ECMO) have cerebral atrophy. Magnetic resonance imaging (MRI) has shown that the N-acetylaspartate/creatine (NAA/Cr) ratio ...

see more →

Patient Education  2 results see all →